Your browser doesn't support javascript.
loading
Drug-Induced Autoimmune Hepatitis: An Unusual Adverse Event of Atorvastatin Therapy.
Patel, Mitwa; Fattah, Abdul; Hussaini, Helai; Maneesha, Fnu; Ahmed, Zahoor.
Affiliation
  • Patel M; Internal Medicine, David Tvildiani Medical University, Tbilisi, GEO.
  • Fattah A; Internal Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, PAK.
  • Hussaini H; Internal Medicine, West Anaheim Medical Center, Anaheim, USA.
  • Maneesha F; Internal Medicine, Ghulam Mohammad Mahar Medical College, Sukkur, PAK.
  • Ahmed Z; Internal Medicine, Mayo Hospital, Lahore, PAK.
Cureus ; 16(3): e55809, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38586640
ABSTRACT
Drug-induced autoimmune hepatitis (AIH) is characterized by acute or chronic hepatic injury coupled with autoantibody development, hypertransaminasemia, and idiopathic AIH features on liver biopsy. Atorvastatin-induced AIH is a rare but well-documented life-threatening adverse event. We report a case of atorvastatin-induced AIH in a 57-year-old female who presented with worsening fatigue, jaundice, and deranged liver function tests. She had been prescribed atorvastatin 20 mg daily three months prior. Her clinical presentation, imaging findings, and serological testing were suggestive of drug-induced AIH. A liver biopsy confirmed a drug-induced autoimmune picture, and she was diagnosed with atorvastatin-induced AIH after ruling out all other possible causes. Her clinical presentation and liver enzymes improved after prolonged treatment with prednisone.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article Country of publication: United States